A randomized phase II study of paclitaxel-carboplatin-bevacizumab (PCB) with or without nitroglycerin patches (NTG) in patients (pts) with stage IV nonsquamous non-small cell lung cancer (NSCLC): Nvalt 12 (NCT01171170).
Anne-Marie C. Dingemans
No relevant relationships to disclose
Harry J.M. Groen
No relevant relationships to disclose
Judith Herder
No relevant relationships to disclose
Jos Stigt
No relevant relationships to disclose
Egbert F. Smit
No relevant relationships to disclose
Idris Bahce
No relevant relationships to disclose
Otilia Dalesio
No relevant relationships to disclose
Sjaak A. Burgers
No relevant relationships to disclose
Henk Codrington
No relevant relationships to disclose
BEN VAN Den Borne
No relevant relationships to disclose
Bonne Biesma
No relevant relationships to disclose
Andrew D. Vincent
No relevant relationships to disclose
Vincent van de Noort
No relevant relationships to disclose
Joachim Aerts
No relevant relationships to disclose